Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma
2016 ◽
Vol 34
(15_suppl)
◽
pp. 8001-8001
◽
2012 ◽
Vol 53
(12)
◽
pp. 2507-2510
◽
2014 ◽
Vol 55
(12)
◽
pp. 2967-2969
◽
2019 ◽
Vol 25
(3)
◽
pp. S281
Keyword(s):
2018 ◽
Vol 24
(3)
◽
pp. S134